Vertex Pharmaceuticals

-$0.53 (-0.23%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

CEO
Reshma Kewalramani
Employees
3,400
Headquarters
Boston, Massachusetts
Founded
1989

VRTX Key Statistics

Market cap
58.26B
Price-Earnings ratio
27.27
Dividend yield
—
Average volume
1.93M
High today
$229.81
Low today
$225.01
Open price
$226.62
Volume
2.00M
52 Week high
$234.96
52 Week low
$176.36

VRTX News

Benzinga7h

Recap: Vertex Pharmaceuticals Q4 Earnings

Vertex Pharmaceuticals (NASDAQ:VRTX) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:01 PM. Here's what investors need to know about the
BenzingaJan 20

Where Vertex Pharmaceuticals Stands With Analysts - Vertex Pharmaceuticals

Over the past 3 months, 6 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wa

VRTX Earnings

$2.07
$2.57
$3.06
$3.56
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
$3.29 per share
Actual
$3.37 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure